Lexeo Therapeutics (LXEO) Retained Earnings (2022 - 2026)
Lexeo Therapeutics recorded quarterly Retained Earnings of -$142000.0 in Q1 2026, down 175.53% quarter-over-quarter from $188000.0 in Q4 2025, and up 99.95% year-over-year from -$71016.1 in Q1 2025.
Lexeo Therapeutics' Retained Earnings history runs 5 years deep, the most recent figure standing at -$142000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.95% year-over-year to -$142000.0; the TTM figure through Mar 2026 stood at -$142000.0 (up 99.95% YoY), while the FY2025 annual figure was $188000.0, up 100.07% from the prior year.
- Retained Earnings came in at -$142000.0 for Q1 2026 at Lexeo Therapeutics, down from $188000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $188000.0 in Q4 2025 to a low of -$338.9 million in Q2 2025.
- A 5-year average of -$175.0 million and a median of -$203.3 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 57.51% in 2023 and soared 100.07% in 2025, its largest moves.
- Lexeo Therapeutics' Retained Earnings stood at -$115.4 million in 2022, then slumped by 57.51% to -$181.8 million in 2023, then plunged by 54.08% to -$280.2 million in 2024, then surged by 100.07% to $188000.0 in 2025, then slumped by 175.53% to -$142000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$142000.0, $188000.0, and $89000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | -142,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,000.00 |
| Dec 31, 2025 | 188,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | -338.90 Mn |
| Mar 31, 2025 | -312.83 Mn |
| Dec 31, 2024 | -280.17 Mn |
| Sep 30, 2024 | -254.25 Mn |
| Jun 30, 2024 | -224.76 Mn |
| Mar 31, 2024 | -224.80 Mn |
| Dec 31, 2023 | -181.84 Mn |
| Sep 30, 2023 | -167.65 Mn |
| Dec 31, 2022 | -115.45 Mn |